Evaxion Biotech (EVAX) Announces Clinical Collaboration with Merck (MRK) to Evaluate Lead Product Candidate with KEYTRUDA

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. DOL:CN

Go back to Evaxion Biotech (EVAX) Announces Clinical Collaboration with Merck (MRK) to Evaluate Lead Product Candidate with KEYTRUDA
(NASDAQ: EVAX) Delayed: 3.64 +0.03 (0.83%)
Previous Close $3.61    52 Week High $ 
Open $3.55    52 Week Low $ 
Day High $3.90    P/E N/A 
Day Low $3.55    EPS $ 
Volume 58,940       

Merck & Co. (NYSE: MRK) Delayed: 119.05 -1.71 (1.42%)
Previous Close $120.76    52 Week High $65.46 
Open $121.50    52 Week Low $47.97 
Day High $121.90    P/E 80.99 
Day Low $118.83    EPS $1.47 
Volume 10,927,028